Correlation Between Lyc Healthcare and Duopharma Biotech

Can any of the company-specific risk be diversified away by investing in both Lyc Healthcare and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyc Healthcare and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyc Healthcare Bhd and Duopharma Biotech Bhd, you can compare the effects of market volatilities on Lyc Healthcare and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyc Healthcare with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyc Healthcare and Duopharma Biotech.

Diversification Opportunities for Lyc Healthcare and Duopharma Biotech

-0.34

Correlation Coefficient

Lyc Healthcare  Duopharma Biotech

Very good diversification

The 3 months correlation between Lyc and Duopharma is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Lyc Healthcare Bhd and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and Lyc Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyc Healthcare Bhd are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of Lyc Healthcare i.e., Lyc Healthcare and Duopharma Biotech go up and down completely randomly.

Pair Corralation between Lyc Healthcare and Duopharma Biotech

Assuming the 90 days trading horizon Lyc Healthcare Bhd is expected to under-perform the Duopharma Biotech. In addition to that, Lyc Healthcare is 2.52 times more volatile than Duopharma Biotech Bhd. It trades about -0.04 of its total potential returns per unit of risk. Duopharma Biotech Bhd is currently generating about -0.02 per unit of volatility. If you would invest  158.00  in Duopharma Biotech Bhd on October 22, 2024 and sell it today you would lose (34.00) from holding Duopharma Biotech Bhd or give up 21.52% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.79%
Values	Daily Returns

Lyc Healthcare Bhd  vs.  Duopharma Biotech Bhd

Lyc Healthcare Bhd

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Lyc Healthcare Bhd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Lyc Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.

Duopharma Biotech Bhd

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Duopharma Biotech Bhd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Lyc Healthcare and Duopharma Biotech

The main advantage of trading using opposite Lyc Healthcare and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyc Healthcare position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.

The idea behind Lyc Healthcare Bhd and Duopharma Biotech Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.